Información del artículo
El Texto completo está disponible en PDF
Bibliografía
[1.]
M. Chalumeau, S. Tonnelier, P. d'Athis, J.M. Tréluyer, D. Gendrel, G. Bréart, et al.
Fluoroquinolone safety in pediatric patients: A prospective,multicenter cohort study in France.
Pediatrics, 111 (2003), pp. 714-719
[2.]
D. Gendrel, F. Moulin.
Fluoroquinolones in paediatrics.
Pediatr Drugs, 3 (2001), pp. 365-377
[3.]
U.B. Schaad, M.A. Salam, Y. Aujard, R. Dagan, S.D. Green, H. Peltola, et al.
Use of fluoroquinolones in pediatrics: Consensus report of an International Society of Chemotherapy Commission.
Pediatr Infect Dis J, 14 (1995), pp. 1-9
[4.]
B. Hampel, R. Hullmann, H. Schmidt.
Ciprofloxacin in pediatrics, worldwide clinical experience based on compassionate use-safety report.
Pediatr Infect Dis J, 16 (1997), pp. 127-129
[5.]
V. Kréméry, J. Filka, J. Uher, H. Kurak, T. Sagát, J. Tuharsky, et al.
Ciprofloxacin in treatment of nosocomial meningitis in neonates and in infants: Report of 12 cases and review.
Diagn Microbiol Infect Dis, 35 (1999), pp. 75-80
[6.]
D.B. Bethell, T.T. Hien, L.T. Phi.
Effects on growth of single short course of fluoroquinolones.
Arch Dis Child, 74 (1996), pp. 44-46
[7.]
K.G. Naber, D. Adam.
Classification of fluoroquinolones.
Int J Antimicrob Agents, 10 (1998), pp. 255-257
[9.]
D.C. Hooper.
Quinolones.
Mandell, Douglas & Bennett's Principles and Practice of Infectious Disease, 4th ed, pp. 364-376
[10.]
G.M. Eliopoulos, C.T. Eliopoulus.
Activity in vitro of the quinolones.
Quinolone Antimicrobial Agents, 2nd ed, pp. 161-194
[11.]
M.E. Bonafede, J.L. Blumer.
Role of newer broad-spectrum β-lactam and fluoroquinolone antibiotics in children.
Adv Pediatr Infect Dis, 12 (1996), pp. 71-108
[12.]
H. Peltola, M. Vaarala, O. Renkonen, P.J. Neuvonen.
Pharmacokinetics of single-dose ciprofloxacin in infants and small children.
Antimicrob Agents Chemother, 36 (1992), pp. 1086-1090
[13.]
M. Gobernado, E. Romá, C. Planells.
Quinolonas: breve panorama de sus efectos adversos.
Rev Esp Quimioter, 12 (1999), pp. 177-180
[14.]
V. Chysky, K. Kapila, R. Hullmann, G. Arcieri, P. Schacht, R. Echols.
Safety of ciprofloxacin in children. Worldwide clinical experience based on compassionate use. Emphasis on joint evaluation.
Infection, 19 (1991), pp. 289-296
[15.]
J. Dohar, F. Faap.
Evolution of management approaches for otitis extern.
Pediatr Infect Dis J, 22 (2003), pp. 299-308
[16.]
J.O. Klein, G.H. Jr McCracken GH.
The use of topical ofloxacin for otic diseases in infants and children. Summary and conclusions.
Pediatr Infect Dis J, 20 (2001), pp. 123-125
[17.]
E.L. Goldblatt.
Efficacy of ofloxacin and other otic preparations for acute otitis media in patients with tympanostomy tubes.
Pediatr Infect Dis J, 20 (2001), pp. 116-119
[18.]
R. Lang, S. Goshen, A. Raas-rothschild, A. Raz, D. Ophir, B. Wolach.
Oral ciprofloxacin in the management of chronic suppurative otitis media without cholesteatoma in children: preliminary experience in 21 children.
Pediatr Infect Dis J, 11 (1992), pp. 181-215
[19.]
T.T. Rubio.
Ciprofloxacin in the treatment of Pseudomonas infection in children with cystic fibrosis.
Diagn Microbiol Infect Dis, 13 (1990), pp. 153-155
[20.]
American Academy of Pediatrics.
Antimicrobial agents and related therapy.Fluoroquinolones.
Report of the Committee on Infectious Diseases, 25th ed, pp. 645-646
[21.]
C.P. Doherty, S.K. Saha, W.A.M. Cutting.
Typhoid fever, ciprofloxacin and growth in young children.
Ann Trop Paediatr, 20 (2000), pp. 297-303
[22.]
Zimbabwe, Bangladesh, South Africa (Zimbasa) disentery study group.
Multicenter randomized, double blind clinical trial of short course versus standard course oral ciprofloxacin for Shigella dysenteriae type 1 dysentery in children.
Pediatr Infect Dis J, 21 (2002), pp. 1136-1141
[23.]
E. Leibovitz, J. Janco, L. Pigllansky, J. Press, P. Yagupsky, H. Reinhart, et al.
Oral ciprofloxacin vs intramuscular ceftriaxone as empiric treatment of acute invasive diarrhea in children.
Pediatr Infect Dis J, 19 (2000), pp. 1060-1067
[25.]
J.R. Park, J. Coughlin, D. Hawkins, D.L. Friedman, J.L. Burns, T. Pendergrass.
Ciprofloxacin and amoxicillin as continuation treatment of febrile neutropenia in pediatric cancer patients.
Med Pediatr Oncol, 40 (2003), pp. 93-94
[26.]
D. Isaacs, M.P.E. Slack, A.R. Wilkinson, A.W. Westwood.
Successful treatment of Pseudomonas ventriculitis with ciprofloxacin.
J Antimicrob Chemother, 17 (1986), pp. 535-537
[27.]
L.E. Cuevas, P. Kazembe, G.K. Mughogho, G.S. Tillotson, C.A. Hart.
Eradication of nasopharyngeal carriage of Neisseria meningitidis in children and adults in rural Africa: A comparison of ciprofloxacin and rifampin.
J Infect Dis, 171 (1995), pp. 728-731
[28.]
J.D. Nelson, G.H. McCraken.
The pediatric infectious disease journal newsletter.
Fluoroquinolones in pediatrics, (1998), pp. 17
[29.]
L. Dubey, K. Krasinski, M. Hernanz-Schulman.
Osteomyelitis secondary to trauma or infected contiguous soft tissue.
Pediatr Infect Dis J, 7 (1988), pp. 26-34
Copyright © 2004. Elsevier España, S.L.. Todos los derechos reservados